Hargreaves Iain P: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) |
||
Line 15: | Line 15: | ||
== Participated at == | == Participated at == | ||
* [[IOC100]] | ::::* [[IOC100|IOC100 Schroecken AT]] | ||
* [[IOC77]] | ::::* [[IOC77|IOC77 Newport Beach US]] |
Revision as of 15:19, 13 February 2018
Name | Hargreaves Iain, Dr. |
---|---|
Institution | The National Hospital for Neurology & Neurosurgery
Neurometabolic Unit |
Address | 33 Queen Square, WC1N 3BG |
City | London |
State/Province | |
Country | United Kingdom |
[email protected] | |
Weblink | |
O2k-Network Lab | UK London Land JM |
Labels:
Publications
Published | Reference | |
---|---|---|
Turton 2022 Int J Mol Sci | 2022 | Turton N, Cufflin N, Dewsbury M, Fitzpatrick O, Islam R, Watler LL, McPartland C, Whitelaw S, Connor C, Morris C, Fang J, Gartland O, Holt L, Hargreaves IP (2022) The biochemical assessment of mitochondrial respiratory chain disorders. Int J Mol Sci 23:7487. https://doi.org/10.3390/ijms23137487 |
Turton 2021 Expert Opinion Orphan Drugs | 2021 | Turton N, Bowers N, Khajeh S, Hargreaves IP, Heaton RA (2021) Coenzyme Q10 and the exclusive club of diseases that show a limited response to treatment. Expert Opinion on Orphan Drugs 9:151-60. https://doi.org/10.1080/21678707.2021.1932459. |
Mantle 2021 Antioxidants (Basel) | 2021 | Mantle D, Heaton RA, Hargreaves IP (2021) Coenzyme Q10, ageing and the nervous system: an overview. Antioxidants (Basel) 11:2. https://doi.org/10.3390/antiox11010002 |
BEC 2020.1 doi10.26124bec2020-0001.v1 | 2020 | Gnaiger E et al β MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1 |
Hargreaves 2016 Drug Saf | 2016 | Hargreaves IP, Al Shahrani M, Wainwright L, Heales SJR (2016) Drug-induced mitochondrial toxicity. Drug Saf 39:661β74. https://doi.org/10.1007/s40264-016-0417-x. |